Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business UpdatesGlobeNewsWire • 05/11/23
Prime Medicine to Present at Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease DaysGlobeNewsWire • 03/27/23
Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 03/09/23
Gene-editing firm Prime Medicine slips in Nasdaq debut following big biotech IPOProactive Investors • 10/20/22
Prime Medicine sets IPO terms, which could value the biotech at up to $1.7 billionMarket Watch • 10/13/22